Pain

Latest

NICE recommends first oral treatment for migraine prevention

NICE recommends first oral treatment for migraine prevention

Pharmacists need endometriosis education amid slow diagnoses, charity suggests

Pharmacists need endometriosis education amid slow diagnoses, charity suggests

8th March 2024

Ban multi-buy deals on pain relief medicine, government urged

Ban multi-buy deals on pain relief medicine, government urged

7th November 2023

Painkiller use in inflammatory arthritis is ‘widespread’ despite no benefit

Painkiller use in inflammatory arthritis is ‘widespread’ despite no benefit

18th October 2023

Social impact of pain up a quarter in a decade

Social impact of pain up a quarter in a decade

29th September 2023

NICE to recommend rimegepant as first acute migraine treatment

NICE to recommend rimegepant as first acute migraine treatment

18th September 2023

Number of potentially addictive drugs prescribed nearly unchanged in seven years

Number of potentially addictive drugs prescribed nearly unchanged in seven years

7th September 2023

Overdose risk higher when opioid agonists prescribed with other medicines

Overdose risk higher when opioid agonists prescribed with other medicines

11th August 2023

New approval process has sped up medicines access, claims NICE

New approval process has sped up medicines access, claims NICE

13th July 2023

Novel oral drug for migraine prevention approved by NICE

By Sofia Lind

Medicinal cannabis could reduce polypharmacy and opioid use, study suggests

By Emma Wilkinson

Lack of reliable evidence on most antidepressants prescribed for chronic pain

By Emma Wilkinson

Little evidence for analgesics for lower back pain

By Emma Wilkinson

Reluctance to prescribe medication risks the health of pregnant women

By Helen Quinn

Two-fifths of Brits experience chronic pain in their mid-forties, study finds

By Rebecca Jenkins

Cannabis products demonstrate ‘short-term reduction in chronic pain, but little else’, researchers suggest

By Katherine Price